UPDATE - Issue 29 - Spring 2007
20-year predictor
A single prostate-specific antigen test between the ages of 44 and 50 can reliably predict men's risk of prostate cancer up to 20 years later. Scientists at New York's Memorial Sloan-Kettering Cancer Centre say in the Journal of Clinical Oncology (March) that early biochemical changes indicate a predisposition to prostate cancer that can appear two decades before the disease, and may help to identify men who should undergo annual screening.